SKAN Group (7VG) Stock Overview
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 7VG from our risk checks.
7VG Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
SKAN Group AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 64.50 |
| 52 Week High | CHF 70.00 |
| 52 Week Low | CHF 42.80 |
| Beta | 0.74 |
| 1 Month Change | 3.20% |
| 3 Month Change | 21.70% |
| 1 Year Change | 4.03% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -8.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7VG | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | -4.4% | -2.9% | -2.2% |
| 1Y | 4.0% | 5.1% | 3.4% |
Return vs Industry: 7VG underperformed the German Life Sciences industry which returned 7.4% over the past year.
Return vs Market: 7VG matched the German Market which returned 4% over the past year.
Price Volatility
| 7VG volatility | |
|---|---|
| 7VG Average Weekly Movement | 5.6% |
| Life Sciences Industry Average Movement | 6.7% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 12.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 7VG has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 7VG's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 1,694 | Jonas Greutert | skan.com/de/home/ |
SKAN Group AG, together with its subsidiaries, provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally. It operates in two segments, Equipment and Solutions; and Services and Consumables. The company offers accessories, biological indicators, digital ventures, isolators, cleanroom, laminar flow, particle counter, personal protective equipment, safety workbench, transfer systems, and fume cupboard.
SKAN Group AG Fundamentals Summary
| 7VG fundamental statistics | |
|---|---|
| Market cap | €1.50b |
| Earnings (TTM) | €31.76m |
| Revenue (TTM) | €384.81m |
Is 7VG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7VG income statement (TTM) | |
|---|---|
| Revenue | CHF 363.25m |
| Cost of Revenue | CHF 91.10m |
| Gross Profit | CHF 272.15m |
| Other Expenses | CHF 242.17m |
| Earnings | CHF 29.98m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
Mar 23, 2027
| Earnings per share (EPS) | 1.33 |
| Gross Margin | 74.92% |
| Net Profit Margin | 8.25% |
| Debt/Equity Ratio | 104.1% |
How did 7VG perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/14 21:31 |
| End of Day Share Price | 2026/09/14 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
SKAN Group AG is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gerhard Schwarz | Baader Helvea Equity Research |
| Samuel England | Berenberg |
| Odysseas Manesiotis | Berenberg |